Zhou B, Lu Y, Hajifathalian K, Bentham J, Di Cesare M, Danaei G, et al. Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4·4 million participants. Lancet. 2016;387:1513–30.

Article  Google Scholar 

Burge R, Dawson-Hughes B, Solomon DH, Wong JB, King A, Tosteson A. Incidence and economic burden of osteoporosis-related fractures in the United States, 2005–2025. J Bone Miner Res. 2007;22:465–75.

Article  PubMed  Google Scholar 

Massera D, Biggs ML, Walker MD, Mukamal KJ, Ix JH, Djousse L, et al. Biochemical markers of bone turnover and risk of incident diabetes in older women: the cardiovascular health study. Diabetes Care. 2018;41:1901–8.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bonnet N. Bone-derived factors: a new gateway to regulate glycemia. Calcif Tissue Int. 2017;100:174–83.

Article  CAS  PubMed  Google Scholar 

Schwartz AV, Sellmeyer DE, Ensrud KE, Cauley JA, Tabor HK, Schreiner PJ, et al. Older women with diabetes have an increased risk of fracture: a prospective study. J Clin Endocrinol Metab. 2001;86:32–8.

Article  CAS  PubMed  Google Scholar 

Bonds DE, Larson JC, Schwartz AV, Strotmeyer ES, Robbins J, Rodriguez BL, et al. Risk of fracture in women with type 2 diabetes: the Women’s Health Initiative Observational Study. J Clin Endocrinol Metab. 2006;91:3404–10.

Article  CAS  PubMed  Google Scholar 

Janghorbani M, Van Dam RM, Willett WC, Hu FB. Systematic review of type 1 and type 2 diabetes mellitus and risk of fracture. Am J Epidemiol. 2007;166:495–505.

Article  PubMed  Google Scholar 

Fan Y, Wei F, Lang Y, Liu Y. Diabetes mellitus and risk of hip fractures: a meta-analysis. Osteoporos Int. 2016;27:219–28.

Article  CAS  PubMed  Google Scholar 

Vestergaard P. Discrepancies in bone mineral density and fracture risk in patients with type 1 and type 2 diabetes—a meta-analysis. Osteoporos Int. 2007;18:427–44.

Article  CAS  PubMed  Google Scholar 

Giangregorio LM, Leslie WD, Lix LM, Johansson H, Oden A, McCloskey E, et al. FRAX underestimates fracture risk in patients with diabetes. J Bone Miner Res. 2012;27:301–8.

Article  PubMed  Google Scholar 

Leslie WD, Rubin MR, Schwartz AV, Kanis JA. Type 2 diabetes and bone. J Bone Miner Res. 2012;27:2231–7.

Article  PubMed  Google Scholar 

Schwartz AV. Association of BMD and FRAX score with risk of fracture in older adults with type 2 diabetes. JAMA. 2011;305:2184.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Silva BC, Leslie WD, Resch H, Lamy O, Lesnyak O, Binkley N, et al. Trabecular bone score: a noninvasive analytical method based upon the DXA image: TRABECULAR BONE SCORE. J Bone Miner Res. 2014;29:518–30.

Article  PubMed  Google Scholar 

Harvey NC, Glüer CC, Binkley N, McCloskey EV, Brandi M-L, Cooper C, et al. Trabecular bone score (TBS) as a new complementary approach for osteoporosis evaluation in clinical practice. Bone. 2015;78:216–24.

Article  CAS  PubMed  PubMed Central  Google Scholar 

McCloskey EV, Odén A, Harvey NC, Leslie WD, Hans D, Johansson H, et al. A meta-analysis of trabecular bone score in fracture risk prediction and its relationship to FRAX: TBS IN FRACTURE RISK PREDICTION AND RELATIONSHIP TO FRAX. J Bone Miner Res. 2016;31:940–8.

Article  PubMed  Google Scholar 

Leslie WD, Aubry-Rozier B, Lamy O, Hans D, for the Manitoba Bone Density Program. TBS (trabecular bone score) and diabetes-related fracture risk. J Clin Endocrinol Metab. 2013;98:602–9.

Article  CAS  PubMed  Google Scholar 

Dhaliwal R, Cibula D, Ghosh C, Weinstock RS, Moses AM. Bone quality assessment in type 2 diabetes mellitus. Osteoporos Int. 2014;25:1969–73.

Article  CAS  PubMed  Google Scholar 

Kim JH, Choi HJ, Ku EJ, Kim KM, Kim SW, Cho NH, et al. Trabecular bone score as an indicator for skeletal deterioration in diabetes. J Clin Endocrinol Metab. 2015;100:475–82.

Article  CAS  PubMed  Google Scholar 

Kanis JA, Cooper C, Rizzoli R, Reginster J-Y. Scientific advisory Board of the European Society for clinical and economic aspects of osteoporosis (ESCEO) and the committees of scientific advisors and National Societies of the international osteoporosis foundation (IOF). European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int. 2019;30:3–44.

Article  CAS  PubMed  Google Scholar 

Camacho PM, Petak SM, Binkley N, Diab DL, Eldeiry LS, Farooki A, et al. American Association of Clinical Endocrinologists/American College of Endocrinology clinical practice guidelines for the diagnosis and treatment of postmenopausal osteoporosis—2020 update. Endocr Pract. 2020;26:1–46.

Article  PubMed  Google Scholar 

Shepherd JA, Schousboe JT, Broy SB, Engelke K, Leslie WD. Executive summary of the 2015 ISCD position development conference on advanced measures from DXA and QCT: fracture prediction beyond BMD. J Clin Densitom. 2015;18:274–86.

Article  PubMed  Google Scholar 

Manske SL, Zhu Y, Sandino C, Boyd SK. Human trabecular bone microarchitecture can be assessed independently of density with second generation HR-pQCT. Bone. 2015;79:213–21.

Article  CAS  PubMed  Google Scholar 

Link TM. Osteoporosis imaging: state of the art advanced imaging. Radiology. 2012;263:3–17.

Article  PubMed  PubMed Central  Google Scholar 

Rubin MR, Patsch JM. Assessment of bone turnover and bone quality in type 2 diabetic bone disease: current concepts and future directions. Bone Res. 2016;4:16001.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Patsch JM, Burghardt AJ, Yap SP, Baum T, Schwartz AV, Joseph GB, et al. Increased cortical porosity in type 2 diabetic postmenopausal women with fragility fractures. J Bone Miner Res. 2013;28:313–24.

Article  PubMed  Google Scholar 

Dhaliwal R, Rosen C. Type 2 diabetes and aging: a not so sweet scenario for bone. Horm Metab Res. 2016;48:771–8.

Article  CAS  PubMed  Google Scholar 

Burghardt AJ, Issever AS, Schwartz AV, Davis KA, Masharani U, Majumdar S, et al. High-resolution peripheral quantitative computed tomographic imaging of cortical and trabecular bone microarchitecture in patients with type 2 diabetes mellitus. J Clin Endocrinol Metab. 2010;95:5045–55.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Dobnig H, Piswanger-Sölkner JC, Roth M, Obermayer-Pietsch B, Tiran A, Strele A, et al. Type 2 diabetes mellitus in nursing home patients: effects on bone turnover, bone mass, and fracture risk. J Clin Endocrinol Metab. 2006;91:3355–63.

Article  CAS  PubMed  Google Scholar 

Ardawi M-SM, Akhbar DH, AlShaikh A, Ahmed MM, Qari MH, Rouzi AA, et al. Increased serum sclerostin and decreased serum IGF-1 are associated with vertebral fractures among postmenopausal women with type-2 diabetes. Bone. 2013;56:355–62.

Article  CAS  PubMed  Google Scholar 

Yamamoto M, Yamaguchi T, Nawata K, Yamauchi M, Sugimoto T. Decreased PTH levels accompanied by low bone formation are associated with vertebral fractures in postmenopausal women with type 2 diabetes. J Clin Endocrinol Metab. 2012;97:1277–84.

Article  CAS  PubMed  Google Scholar 

Gaudio A, Privitera F, Battaglia K, Torrisi V, Sidoti MH, Pulvirenti I, et al. Sclerostin levels associated with inhibition of the wnt/β-catenin signaling and reduced bone turnover in type 2 diabetes mellitus. J Clin Endocrinol Metab. 2012;97:3744–50.

Article  CAS  PubMed  Google Scholar 

Krakauer JC, Mckenna MJ, Fenn Buderer N, Rao DS, Whitehouse FW, Parfitt AM. Bone loss and bone turnover in diabetes. Diabetes. 1995;44:775–82.

Article  CAS  PubMed  Google Scholar 

Dhaliwal R, Hans D, Hattersley G, Mitlak B, Fitzpatrick LA, Wang Y, et al. Abaloparatide in postmenopausal women with osteoporosis and type 2 diabetes: a post hoc analysis of the ACTIVE study. JBMR Plus [Internet]. 2020 [cited 2022 Feb 14];4. Available from: https://onlinelibrary.wiley.com/doi/10.1002/jbm4.10346.

Farr JN, Drake MT, Amin S, Melton LJ, McCready LK, Khosla S. In vivo assessment of bone quality in postmenopausal women with type 2 diabetes: BONE QUALITY IN WOMEN WITH T2D. J Bone Miner Res. 2014;29:787–95.

Article  PubMed  Google Scholar 

Li Z, Frey JL, Wong GW, Faugere M-C, Wolfgang MJ, Kim JK, et al. Glucose transporter-4 facilitates insulin-stimulated glucose uptake in osteoblasts. Endocrinology. 2016;157:4094–103.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Esen E, Long F. Aerobic glycolysis in osteoblasts. Curr Osteoporos Rep. 2014;12:433–8.

Article  PubMed  PubMed Central  Google Scholar 

Karner CM, Long F. Glucose metabolism in bone. Bone. 2018;115:2–7.

Article  CAS  PubMed  Google Scholar 

Komarova SV, Ataullakhanov FI, Globus RK. Bioenergetics and mitochondrial transmembrane potential during differentiation of cultured osteoblasts. Am J Physiol-Cell Physiol. 2000;279:C1220–9.